Rampart Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Rampart Investment Management's EW Position: Q4 2020 in Review
Rampart Investment Management sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 4,002 shares — an estimated $319K sold.
Rampart Investment Management first reported a position in EW in Q2 2017 and held it in 13 quarters. The position peaked at $1.14M in Q2 2018. 1,159 funds tracked by Wall St. Rank hold EW as of Q4 2020.
- Rampart Investment Management reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
- Rampart Investment Management sold 4,002 Edwards Lifesciences shares in Q4 2020, an estimated $319K.
- Rampart Investment Management first reported a position in Edwards Lifesciences in Q2 2017 and held it in 13 quarters.
- Rampart Investment Management's Edwards Lifesciences position peaked at $1.14M in Q2 2018.
- 1,159 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.
Based on Rampart Investment Management's 13F filing for Q4 2020.